Abiopharma

Clinical trial NCT04387552 updates: 1. enrollment: 2126 → 2093 participants 2. intervention model: FACTORIAL → SEQUENTIAL

Clinical trial NCT07775287: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT04786106 updates: 1. collaborators added: Endo USA Inc., a Keenova Therapeutics Company 2. collaborators removed: Endo Pharmaceuticals

Financial Statements and Related Announcement: Full Yearly Results

Clinical trial NCT06649201: primary completion date: 2026-08-01 → 2026-11-01.

Clinical trial NCT07148323: status: ACTIVE_NOT_RECRUITING → RECRUITING.

Clinical trial NCT06052631: start date: 2026-08-30 → 2026-08-31.

Clinical trial NCT07712874: start date: 2026-08-30 → 2026-08-31.

Clinical trial NCT07586774: start date: 2026-05-30 → 2026-08-30.

Clinical trial NCT07611110 updates: 1. completion date: 2029-12-20 → 2030-06-06 2. primary completion date: 2029-02-13 → 2029-06-04

Clinical trial NCT07680946 updates: 1. start date: 2026-07-03 → 2026-07-27 2. primary completion date: 2028-12-01 → 2028-12-12

Clinical trial NCT06847191: primary completion date: 2026-08-01 → 2026-08-06.

Clinical trial NCT06846281 updates: 1. completion date: 2031-06-24 → 2031-06-25 2. primary completion date: 2029-07-24 → 2029-07-25 3. enrollment: 360 → 400 participants

Clinical trial NCT05276063 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-09-01 → 2025-09-26

Clinical trial NCT07218211 updates: 1. completion date: 2028-01-05 → 2027-07-31 2. primary completion date: 2027-01-05 → 2027-07-31